Transplant Diagnostics Industry Report 2020-2025 - Featuring Profiles of Key Players Thermo Fisher Scientific, Roche, bioMerieux, Bio-Rad Labs, QIAGEN, and Immucor

DUBLIN, Feb. 17, 2020 /PRNewswire/ -- The "Transplant Diagnostics Market - Global Outlook and Forecast 2020-2025" report has been added to's offering.

The global transplant diagnostics market is expected to grow at a CAGR of over 6% during the forecast period 2019-2025.

Key Market Insights

    --  The analysis of the transplant diagnostics market provides sizing and
        growth opportunities for the forecast period 2019-2024.
    --  Provides comprehensive insights on the latest industry trends, forecast,
        and growth drivers in the market.
    --  Includes a detailed analysis of growth drivers, challenges, and
        investment opportunities.
    --  Delivers a complete overview of segments and the regional outlook of the
        transplant diagnostics market.
    --  Offers an exhaustive summary of the vendor landscape, competitive
        analysis, and key strategies to gain a competitive advantage.

The global transplant diagnostics market is growing at a steady rate, which is expected to continue during the forecast period. The high demand for molecular diagnostic tests and the availability of technologically advanced devices with favorable patient demographics are mainly contributing to the high demand for transplant diagnostics devices.

Ongoing technological advancements and innovations witnessed in the development of new genomic, transcriptomic, and proteomic biomarkers, especially in the molecular segment, can provide personalized management for transplantation and can detect rejection episodes and infections early, thereby improving the patient outcomes and success rate.

Transplant Diagnostics Market: Segmentation

This research report includes detailed market segmentation by product, application, technology, transplantation type, end-user, and geography.

The increasing usage of a wide array of reagents and test kits to perform transplant diagnostics tests is a significant factor affecting the growth of the reagents & consumables product segment. The segment is growing at a faster rate than the instruments & software product segment due to their recurring purchase by end-users for performing molecular and non-molecular transplant tests. The growth in technological advancements such as NGS and PCR-based molecular testing techniques is another factor driving the adoption of molecular transplant assays, test kits, and reagents.

The instruments and software segment is growing due to the rise in organ and tissue transplantations and the adoption of advanced techniques. The segment is growing at a relatively slow pace than the consumables & test kits segment as it is capital intensive, and purchasing decisions for these equipment depend on financial resources and budget allocations. However, the recent trends in automation and integration of several medical platforms have led to the introduction of innovative transplant diagnostic analyzers, thereby driving the growth of the segment.

The research application segment is likely to witness faster growth than the clinical application segment as the number of research activities and clinical trials related to transplantation, especially stem cells, is increasing worldwide. The increase in the number of clinical trials and ongoing research activities to improve clinical outcomes is encouraging end-users to effectively screen donors and recipients, perform compatibility assessments and diagnose complications such as organ rejection and infections using molecular and non-molecular tests.

The diagnostics applications segment is growing at a healthy rate and is expected to grow during the forecast period. Transplantation is the treatment of choice for several patients with end-stage organ failure diseases. Significant signs of progress have been achieved both in short-term outcomes and long-term graft survival due to the increasing availability of molecular and serological-based tests to monitor transplant patients. Hence, technological improvements have further increased the application of the segment.

The growing number of solid organ and stem cell replacement, advances in organ transplantation, increase in funding and research grants, and improved public-private investments, and the shift from serological-based tests to gene-based HLA profiling are major factors contributing the growth of the segment. The growing adoption of molecular-based techniques in transplantations with the wide availability of PCR and sequence-based products is contributing to the growth of the segment.

Advances in serology and cellular assays have broadened the scope of transplant immunology technologies. Non-molecular tests have also been contributing sizeable revenues to the global transplant diagnostics market. Their potential in antibody-based histocompatibility tests, especially for lymphocyte micro cytotoxicity testing, has been fueling the demand. Several vendors are offering non-molecular testing products, which is further contributing to the growth.

Solid-organ transplantation has become vital in treating patients suffering from terminal illnesses. Therefore, the global number of solid organ transplantations is increasing at a healthy rate despite interruptions in the organ donation supply mechanism. Incidences of end-stage organ failures are high among patients with chronic diseases, thereby increasing the need for solid organ transplantations. The growth in hematological cancer cases is a key factor for the increasing demand for stem cell therapy worldwide.

Standard reference laboratories conduct tests to identify donor receiver compatibility pre-transplantation. As the number of organs, cells, and tissue replacements is growing worldwide, the demand for laboratory testing is likely to rise at a steady rate. Government financial support for these laboratories is another major factor for the growth of the segment. Academic institutes & research laboratories end-users are growing at a healthy rate as these centers conduct research studies for evaluating the efficacy and safety of immunosuppressive therapies for organs, cell, and tissue replacements.

Healthcare professionals in hospitals and transplant centers use various instruments, accessories, and software for conducting pre and post-transplantation diagnostics tests. The market is growing at a healthy rate due to the adoption of advanced instruments accessories and software for organs, cells, and tissue transplantations. The availability of skilled healthcare professionals to perform diagnostics tests also attracts more patients to hospitals and transplant centers. Also, favorable reimbursement for transplant diagnostics is another factor boosting the end-user segment.

Insights by Geography

The presence of a large pool of the patient population with terminal diseases and the high acceptance of advanced and innovative molecular procedures for transplant diagnostics have collectively supported the growth. France, the UK, Spain, Germany, and Italy are the major revenue contributors to the Europe market. The availability of highly sophisticated healthcare infrastructure and high awareness of advanced transplant procedures are contributing to the growth during the forecast period.

The APAC region has the largest population density and the highest proportion of various chronic diseases. China is the major revenue contributor in APAC. The region is expected to witness significant growth due to advancements in healthcare infrastructure, the rise in healthcare expenditure, and favorable public and private initiatives.

Insights by Vendors

The global transplant diagnostics market is moderately competitive and characterized by the presence of a few players offering these products. It is consolidated with a few players accounting for around 75% of the overall market in 2019. The market is witnessing rapid technological advancements, especially in the molecular diagnostics segment. Moreover, key players are witnessing increased competition from various regional and local players globally.

Key Topics Covered

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of the Study
4.4 Market Segments
4.4.1 Market Segmentation by Products
4.4.2 Market Segmentation by Applications
4.4.3 Market Segmentation by Technology
4.4.4 Market Segmentation by Transplantation
4.4.5 Market Segmentation by End-users
4.4.6 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance

7 Introduction
7.1 Transplant Diagnostics: Overview
7.1.1 Background
7.1.2 Role of Diagnostics in Transplantations

8 Market Dynamics
8.1 Market Growth Enablers
8.1.1 Increasing Number of Transplantations & Prevalence of Chronic Diseases
8.1.2 Rising Incidence of Infections Caused by Transplantations
8.1.3 Increasing Shift from Serological to Molecular Diagnostic Testing in Transplant Patients
8.1.4 Technological Advancements in Transplant Diagnostics
8.2 Market Growth Restraints
8.2.1 Increasing Gap Between Number of Organ Donors & Recipients
8.2.2 Ethical Challenges Related to Organ Procurement and Transplantation
8.2.3 High Costs Associated with Transplant Diagnostics
8.3 Market Opportunities and Trends
8.3.1 Emergence of cfDNA in Transplant Diagnostics
8.3.2 Growing Demand for Transplant Diagnostics in Emerging Economies
8.3.3 Increasing Focus on Identifying Novel Biomarkers for Minimizing Transplantation Rejection

9 Global Transplant Diagnostics Market
9.1 Market Overview
9.2 Market Size & Forecast
9.3 Five Forces Analysis
9.3.1 Threat of New Entrants
9.3.2 Bargaining Power of Suppliers
9.3.3 Bargaining Power of Buyers
9.3.4 Threat of Substitutes
9.3.5 Competitive Rivalry

10 By Products
10.1 Market Snapshot & Growth Engine
10.2 Market Overview
10.3 Consumables & Test Kits
10.4 Instruments & Software

11 By Applications
11.1 Market Snapshot & Growth Engine
11.2 Market Overview
11.3 Diagnostic Applications
11.4 Research Applications

12 By Technology
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Molecular Tests
12.4 Non-molecular

13 By Transplantation
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Solid Organ Transplantation
13.4 Soft Tissue Transplantation

14 By End-users
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Standard Reference Laboratories
14.4 Hospitals & Transplant Centers
14.5 Academic Institutes & Research Laboratories

15 By Geography
15.1 Market Snapshot & Growth Engine
15.2 Overview

16 North America

17 Europe


19 Latin America

20 Middle East & Africa

21 Competitive Landscape
21.1 Competition Overview
21.2 Market Share Analysis
21.2.1 Thermo Fisher Scientific
21.2.2 F. Hoffmann-La Roche
21.2.3 bioMerieux
21.2.4 Bio-Rad Laboratories
21.2.5 QIAGEN
21.2.6 Immucor

22 Key Company Profiles
22.1 Thermo Fisher Scientific
22.1.1 Business Overview
22.1.2 Major Product Offerings
22.1.3 Key Strengths
22.1.4 Key Strategies
22.1.5 Key Opportunities
22.2 F. Hoffmann-La Roche
22.3 bioMerieux
22.4 Bio-Rad Laboratories
22.6 Immucor

23 Other Prominent Vendors
23.1 BAG Diagnostics
23.1.1 Business Overview
23.1.2 Major Product Offerings
23.2 CareDx
23.3 ELITechGroup
23.4 Genome Diagnostics
23.5 Illumina
23.6 NanoString Technologies
23.7 Omixon
23.8 Transplant Genomics
23.9 Wakunaga Pharmaceutical

For more information about this report visit

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:

SOURCE Research and Markets